Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

1933 Industries Inc C.TGIF

Alternate Symbol(s):  TGIFF

1933 Industries Inc. is a Canada-based cannabis cultivator and producer. The Company is focused on the cultivation and manufacturing of a portfolio of cannabis consumer-packaged goods in a variety of formats for both the wholesale and retail markets. The Company operates through three segments: Alternative Medicine Association LLC (AMA), Infused Mfg LLC (Infused MFG), and Corporate. Its AMA segment is focused on the cultivation and sale of medical and adult use cannabis products. Its Infused MFG segment is focused on the manufacturing of Hemp derived cannabidiol (CBD) products. Its product offerings through its in-house brands, including wholesale flower, pre-rolls, and extracted products under the AMA and Level X brands for the Nevada market; and Canna Hemp, a national CBD brand of wellness products, which include tinctures, gummies, topicals and sports recovery products. The Company owns 91% of AMA, and 100% of Infused MFG LLC Infused.


CSE:TGIF - Post by User

Bullboard Posts
Comment by Mangler85on Aug 31, 2018 11:56am
64 Views
Post# 28549046

RE:RE:RE:RE:MAX STOCK PRICE ?

RE:RE:RE:RE:MAX STOCK PRICE ?5years acquisition s and mergers will happen we will be 20bucks.
+ Or we be bought and end up with a vertically integrated company thats nation wide . [medmen]

or we become a top line brand and obtain  distribution contracts across the states all directions point up unless Jeff sessions comes in with the big boys start shooting people for cash .


mangler 


theres lots of scenarios  that could happe  and most are winners imo


theTransporter wrote: You did forget that all this logic goes out the window when it comes to Cannabis stocks.  90% of the valuations of the Canadian LPs dont' follow this logic as Canopy is yet to achieve $250 million per year revenue with their $12.7 billion valuation.  If you want stocks that follow fundamentals stricly, leave thi sector and get into the resources otherwise logic is illogical here and personally I like it as I'm here to make $$.

Let this go up to $3 or $4 and you can come tell me that it's incorrect and overvalued all you want but I wouldn't give two sh1ts about your opinion while I'm counting my cash.

Your logic also doens't even apply to the likes of stocks like Tesla and Amazon so I don't know why you're so anal when it comes to cananbis venture stocks.

BaitingBateman wrote: First - FNI's latest investor presentation provides the following revenue estimations:
2018 - $15m
2019 - $32m
2020 - $37m
2021 - $48m
2022 - $58m
2023 - $67m

The companies 5-year forecast does not project them hitting $80m - why would you assume that's a possibility in the next year?

Second, assuming they did hit $80m a year, maintained 25% GP and achieved a 1:20 PE valuation -

230m shares issued to date.
270m shares issued upon closing of the current financing (assuming fully subscribed)
310m shares issued if all warrants associated with the current financing are excercised.
40m shares currently reserved for issuance. 

$400m / 270m = $1.48 per share
$400m / 310m - $1.29 per share
$400m / 350m = $1.14 per share

If this company is to hit a $4 per share price, under the 1:20 PE valuation, with 300m shares issued and a GP of 25%, they will need to be achieving $240m a year in revenue with $60m in GP.


Walterthedog wrote: my thoughts are that when they complete the new ama expansion they will have 6 times more product and if they can sell all that, the revenue could be 80m per year or more. if they can cut 20m in profit with a PE ratio of 20:1 , it would make the company fundamentally worth 400m$. of course other growth factors could add value but thats the meat and potatoes im hoping for next year

 




Bullboard Posts